Over the last 50 years, IMS has invested on R&D, Production and Quality Management, working together with radiologists and radiographers to improve image quality and simplify procedures, with the outcome of the most advanced breast imaging technology. Thanks to this continuous commitment, early detection of breast cancer is now achievable around the world, improving women’s health.
IMS GIOTTO is constantly engaged in the research and development of the latest technologies in breast imaging field.
The high quality and excellent clinical performance of our products are the result of continuous controls along the whole process, from software design and hardware manufacturing to the final product.
Mission and Vision >
We use our many decades of experience in diagnostic imaging technologies all through our continuous research and testing of mammography systems to drive the evolution of the technology designed and produced by IMS Giotto.
Our greatest ambition is to produce high-performance systems that aid clinicians in the timely detection and accurate diagnosis of breast lesions anywhere in the world, ultimately serving the healthcare of women.
IMS – INTERNAZIONALE MEDICO SCIENTIFICA S.r.l. was born thanks to the initiative of Mr. Bruno Toniolo, the founder. From the very beginning the Company established itself also in the X-ray products and conventional radiography units.
IMS founded a dedicated R&D department to design the first mammography system; in only a few years IMS grew and became one of the leading names in mammography field.
IMS marketed the first Full Field Digital Mammography unit made in Europe, which has continuously evolved through the years and became GIOTTO IMAGE 3DL: an outstanding mammography unit combining the traditional ring-shaped gantry, for better access, with the most advanced generation of Amorphous Selenium detector.
The combination with the Mammobed unit created a 2-in-1 system for mammography and prone biopsy using the same detector.
IMS began to investigate Tomosynthesis technology and was the first company to explore the technological approach of using the Step and Shoot Scan, variable angle and variable dose.
IMS launched Giotto Tomo, the first mammography unit made by IMS with Digital Breast Tomosynthesis (DBT), optimized to provide excellent image quality with a low dose.
IMS improved the Giotto Tomo system offering a more performing detector and an improved “combo” modality. New and old systems could then be equipped with CANOVA, a proprietary iterative reconstruction algorithm.
IMS was successful in the creation of a unit combining Mammography, Tomosynthesis and (prone) Biopsy: the Giotto Class, whose unicity is granted by international patents and greatly appreciated around the world.
IMS GIOTTO S.P.A. was born as part of the GENERAL MEDICAL MERATE S.P.A. group, a well-known operator in the diagnostic radiology sector, based in Seriate (Bergamo), of which Mr. Massimo Sordi is Chairman.
A new variant was added to the CLASS systems portfolio, with the same imaging performances but with a compact design and fast operation for optimal screening workflow: the Giotto Class S.
A new modality was introduced in the multi-purpose Giotto Class: contrast enhanced spectral mammography (CESM) became possible with a software upgrade.
IMS Giotto adds to the products portfolio its first in-vitro diagnostic medical device: Smart Checker, for the safe storage and imaging of the breast biopsy samples.
With this accessory the versatility of Giotto CLASS is further enriched.
Two new categories of medical devices are added to IMS GIOTTO Class products:
Raffaello, as a stand-alone medical software
Raffaello Plus: a digitalization retrofit kit for radiological equipment, powered by Raffaello.
IMS Giotto never rests and will soon bring breast imaging into the future thanks to AI integration and CESM-guided biopsy.